Carl Turner
Family Medicine · McPherson, KSNPI 1659784296
Payments from drug & device makers
Across 89 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$341
- Pfizer$229
- Lilly USA, LLC$129
- AstraZeneca$115
- Novo Nordisk$82
- Sanofi Pasteur Inc.$69
- plus $536 from 19 others
What the payments were for
- Food & beverage$1,43195%
- Gifts$695%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $341 |
| Pfizer | 14 | $229 |
| Lilly USA, LLC | 9 | $129 |
| AstraZeneca | 7 | $115 |
| Novo Nordisk | 6 | $82 |
| Sanofi Pasteur Inc. | 2 | $69 |
| Amgen | 4 | $57 |
| Boehringer Ingelheim | 3 | $48 |
| Boston Scientific | 2 | $48 |
| Medtronic | 1 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Si-bone, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Astellas Pharma US Inc | 2 | $27 |
| Sumitomo Pharma America, Inc. | 2 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Organon | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Novartis | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$1,500 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 85 | $66,095 |
| MounjaroTirzepatide | 53 | $64,638 |
| EliquisApixaban | 48 | $33,941 |
| OzempicSemaglutide | 30 | $24,608 |
| TrulicityDulaglutide | 22 | $20,875 |
| RybelsusSemaglutide | 17 | $15,884 |
| FarxigaDapagliflozin Propanediol | 16 | $14,996 |
| LinzessLinaclotide | 12 | $6,430 |
| MyrbetriqMirabegron | 14 | $6,296 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $5,358 |
| Aripiprazole | 36 | $4,474 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,346 |
| RivastigmineRivastigmine Tartrate | 11 | $2,135 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 19 | $1,594 |
| Atorvastatin Calcium | 210 | $1,535 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30 | $129 | $86,752102 claims |
| Boehringer IngelheimJardiance | $48 | $66,09585 claims |
| Novo NordiskOzempic, Rybelsus | $82 | $40,49147 claims |
| PfizerEliquis | $229 | $33,94148 claims |
| AstraZenecaFarxiga | $115 | $14,99616 claims |
| AbbVieLinzess, Synthroid | $341 | $7,08526 claims |
| Astellas Pharma US IncMyrbetriq | $27 | $6,29614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in McPherson
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.